Israel Englander’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.7M | Buy |
+625,658
| New | +$14.6M | 0.01% | 1730 |
|
|
2025
Q4 | – | Sell |
-27,698
| Closed | -$707K | – | 6021 |
|
|
2025
Q3 | $707K | Buy |
27,698
+783
| +3% | +$18.6K | ﹤0.01% | 4864 |
|
|
2025
Q2 | $580K | Sell |
26,915
-361,589
| -93% | -$8.15M | ﹤0.01% | 4803 |
|
|
2025
Q1 | $8.87M | Sell |
388,504
-756,843
| -66% | -$19.9M | ﹤0.01% | 2306 |
|
|
2024
Q4 | $29.7M | Buy |
1,145,347
+377,111
| +49% | +$9.38M | 0.01% | 1195 |
|
|
2024
Q3 | $19.2M | Sell |
768,236
-240,961
| -24% | -$5.69M | 0.01% | 1582 |
|
|
2024
Q2 | $21.6M | Sell |
1,009,197
-803,853
| -44% | -$15.6M | 0.01% | 1421 |
|
|
2024
Q1 | $33.6M | Sell |
1,813,050
-499,600
| -22% | -$8.74M | 0.01% | 1113 |
|
|
2023
Q4 | $37.6M | Sell |
2,312,650
-214,359
| -8% | -$2.73M | 0.02% | 1008 |
|
|
2023
Q3 | $34.9M | Buy |
2,527,009
+1,809,201
| +252% | +$28.5M | 0.02% | 962 |
|
|
2023
Q2 | $15.9M | Buy |
717,808
+238,402
| +50% | +$5.02M | 0.01% | 1602 |
|
|
2023
Q1 | $10.4M | Sell |
479,406
-190,796
| -28% | -$4.29M | 0.01% | 1925 |
|
|
2022
Q4 | $12.2M | Sell |
670,202
-98,110
| -13% | -$2.03M | 0.01% | 1909 |
|
|
2022
Q3 | $17.5M | Sell |
768,312
-791,825
| -51% | -$16.9M | 0.01% | 1484 |
|
|
2022
Q2 | $21.5M | Buy |
1,560,137
+486,631
| +45% | +$7.14M | 0.01% | 1236 |
|
|
2022
Q1 | $24.4M | Buy |
1,073,506
+534,735
| +99% | +$14.1M | 0.01% | 1182 |
|
|
2021
Q4 | $20.1M | Buy |
538,771
+369,890
| +219% | +$15.9M | 0.01% | 1434 |
|
|
2021
Q3 | $7.15M | Sell |
168,881
-491,755
| -74% | -$23.7M | ﹤0.01% | 2464 |
|
|
2021
Q2 | $29.4M | Buy |
660,636
+201,959
| +44% | +$7.12M | 0.02% | 910 |
|
|
2021
Q1 | $16.5M | Buy |
458,677
+350,290
| +323% | +$13.9M | 0.01% | 1260 |
|
|
2020
Q4 | $4.32M | Sell |
108,387
-403,429
| -79% | -$13.8M | ﹤0.01% | 2579 |
|
|
2020
Q3 | $14.8K | Buy |
511,816
+442,476
| +638% | +$9.56M | 0.02% | 968 |
|
|
2020
Q2 | $1.13M | Buy |
69,340
+19,746
| +40% | +$272K | ﹤0.01% | 2920 |
|
|
2020
Q1 | $471K | Sell |
49,594
-39,045
| -44% | -$536K | ﹤0.01% | 2915 |
|
|
2019
Q4 | $1.43M | Buy |
88,639
+28,065
| +46% | +$456K | ﹤0.01% | 2807 |
|
|
2019
Q3 | $1.01M | Buy |
60,574
+28,154
| +87% | +$528K | ﹤0.01% | 2850 |
|
|
2019
Q2 | $550K | Sell |
32,420
-70,131
| -68% | -$1.22M | ﹤0.01% | 3160 |
|
|
2019
Q1 | $1.83M | Buy |
102,551
+91,233
| +806% | +$1.45M | ﹤0.01% | 2467 |
|
|
2018
Q4 | $136K | Sell |
11,318
-201,892
| -95% | -$2.41M | ﹤0.01% | 3500 |
|
|
2018
Q3 | $3.73M | Buy |
213,210
+59,805
| +39% | +$1.18M | ﹤0.01% | 2016 |
|
|
2018
Q2 | $1.75M | Sell |
153,405
-88,065
| -36% | -$802K | ﹤0.01% | 2490 |
|
|
2018
Q1 | $1.23M | Buy |
241,470
+58,920
| +32% | +$319K | ﹤0.01% | 2588 |
|
|
2017
Q4 | $1.09M | Buy |
182,550
+164,324
| +902% | +$947K | ﹤0.01% | 2648 |
|
|
2017
Q3 | $104K | Buy |
+18,226
| New | +$75.6K | ﹤0.01% | 3352 |
|
Other funds holding BLFS
CC
FAM
Israel Englander's BLFS Position: Q2 2026 in Review
Israel Englander opened a new position in BioLife Solutions (BLFS) in Q2 2026: 625,658 shares worth $17.7M. The stake represents 0.01% of the portfolio and ranks #1730 among its holdings. This is a return to the name: Israel Englander previously reported a position in BLFS as recently as Q3 2025.
Israel Englander first reported a position in BLFS in Q3 2017 and has held it in 34 quarters since. The position peaked at $37.6M in Q4 2023. 215 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.
- Israel Englander held 625,658 shares of BioLife Solutions worth $17.7M as of Q2 2026.
- BioLife Solutions was a new Israel Englander position in Q2 2026.
- BioLife Solutions made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1730 holding.
- Israel Englander first reported a position in BioLife Solutions in Q3 2017 and has held it in 34 quarters since.
- Israel Englander's BioLife Solutions position peaked at $37.6M in Q4 2023.
- 215 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.